Heterogeneous antibody response to polyvalent melanoma vaccines in syngeneic mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 4, p. 345, doi. 10.1007/s00262-004-0606-9
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2005 AND VI 54 AND IP 4
Results: 14
1
2
Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family members.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 4, p. 359, doi. 10.1007/s00262-004-0592-y
- By:
- Publication type:
- Article
3
Phenotype and function of human natural killer cells purified by using a clinical-scale immunomagnetic method.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 4, p. 389, doi. 10.1007/s00262-004-0609-6
- By:
- Publication type:
- Article
4
Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 4, p. 400, doi. 10.1007/s00262-004-0603-z
- By:
- Publication type:
- Article
5
Distribution of labelled anti-tenascin antibodies and fragments after injection into intact or partly resected C6-gliomas in rats.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 4, p. 337, doi. 10.1007/s00262-004-0608-7
- By:
- Publication type:
- Article
6
Uptake and presentation of malignant glioma tumor cell lysates by monocyte-derived dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 4, p. 372, doi. 10.1007/s00262-004-0615-8
- By:
- Publication type:
- Article
7
BCL1 lymphoma protection induced by idiotype DNA vaccination is entirely dependent on anti-idiotypic antibodies.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 4, p. 351, doi. 10.1007/s00262-004-0579-8
- By:
- Publication type:
- Article
8
Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine model.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 4, p. 383, doi. 10.1007/s00262-004-0614-9
- By:
- Publication type:
- Article
9
Targeting the silent minority: emerging immunotherapeutic strategies for eradication of malignant stem cells in chronic myeloid leukaemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 4, p. 297, doi. 10.1007/s00262-004-0573-1
- By:
- Publication type:
- Article
10
Acquisition of multidrug resistance by L1210 leukemia cells decreases their tumorigenicity and enhances their susceptibility to the host immune response.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 4, p. 328, doi. 10.1007/s00262-004-0588-7
- By:
- Publication type:
- Article
11
Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 4, p. 315, doi. 10.1007/s00262-004-0597-6
- By:
- Publication type:
- Article
12
Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 4, p. 307, doi. 10.1007/s00262-004-0593-x
- By:
- Publication type:
- Article
13
Identification of the protein components of protein-bound polysaccharide (PSK) that interact with NKL cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 4, p. 395, doi. 10.1007/s00262-004-0601-1
- By:
- Publication type:
- Article
14
Acknowledgement to Reviewers in 2004.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 4, p. 407, doi. 10.1007/s00262-004-0658-x
- Publication type:
- Article